Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

TMT Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2018

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Neuromodulation Device Market - Innovations & Trends Webinar: 24 October 2018

Entries for the CARE Awards 2019 are now open

Enter now

Japan Pharma Outlook 2027 Report

Download extract

What's on the horizon for Neuropathic Pain?

Find out more

Welcome to your Pharma Intelligence advantage

Market intelligence

We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.

News and insight

We provide unrivalled and daily-updated global insight, drawn from extensive authoritative data sets and enriched by human validation.

Data and analytics

Our premium quality data is drawn from 42,000 companies, 248,000 clinical trials in 175 countries and 65,000 drugs for 1,400 diseases.

Consultancy

Our bespoke clinical, commercial and market access solutions are designed to help you make smarter decisions that bring a better return on investment.

Global industry experts

Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.

Trusted partnerships

We’re the trusted partner of more than 3,000 companies including the top 50 pharma firms and top 10 contract research organizations.

Gold-standard service

Our customer services team will support you every step of the way so that our insight, intelligence and bespoke solutions match your needs.

Tailor-made solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round your exact needs.

Our Specialties

Clinical trial intelligence

Gain a competitive edge with comprehensive clinical trial intelligence. Find out what competitors are doing in key areas, understand regulations, view clinical trial and program timelines, identify sites and investigators.

Competitive and market intelligence

See the entire global biopharma and medtech market landscape in one place – our expert analysis and trusted databases cover all sectors of the industry.

business development licensing pharma intelligence

Business development and licensing

Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.

business portfolio strategy pharma intelligence

Pharmaceutical portfolio strategy

Identify M&A targets and partnership opportunities, and develop business cases with our real-time intelligence, tools and analysis.

Regulatory approval

An increasingly complex regulatory framework for the pharmaceutical, biotech and medtech industries presents growing challenges to businesses. We’ll help you stay ahead.

medtech competitive intelligence pharma intelligence

Medtech market intelligence

To succeed in medtech, you need to have your finger on the pulse – we’ll help you access the accurate, reliable information you need.

View more
View Less

Our trusted Pharma Intelligence brands

Datamonitor Healthcare

Better Heart Health Whitepaper

22 Oct 2018

In recognition of World Heart Day, September 29, 2018, Informa Pharma Intelligence would like to invite you to download our latest whitepaper, Better Heart Health with Mobile Apps? The Impact of Mobile Apps on Coronary Heart Disease in the US. This exploration into the results of a recent analysis of the US Behavioral Risk Factor Surveillance System (BRFSS), coupled with an analysis of several health apps targeting coronary heart disease (CHD) and other heart disease factors, is available to you now – for free.

View white paper
Biomedtracker

Biomedtracker Q4 2018 Outlook Report

19 Oct 2018

Find out what’s in store for the remainder of 2018 with your copy of the Biomedtracker Q4 2018 Outlook Report Extract. This essential analysis of expected Q4 catalysts for 27 drugs is now available to you – for free. Drawn from the full report of the same name, this vital resource explores the likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) based on a drug’s phase, drug class, and disease group.

Topic Drug development landscape

Single report
Trialtrove

2017 Completed Trials

By Christine Blazynski, PhD 19 Oct 2018

As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were a total of 3,534 Phase I through Phase III/IV. The nearly 700 trials terminated in 2017 were not included in this analysis.

Topic Clinical trials

View white paper
Citeline, Trialtrove

Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

By Laura Runkel 19 Oct 2018

Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.

View white paper
Medtech Insight

Proposed 510(k) Changes Elicit Some Industry Skepticism

By Elizabeth Orr 18 Oct 2018

Two 510(k) pilots from US FDA indicate the agency's desire for faster, easier clearances. But some observers aren’t sure if they’ll lead to real improvements.

Topic FDA

View article
Pink Sheet

DTC Advertising: The 'Kick Me' Sign On Big Pharma's Backs

By Michael McCaughan 18 Oct 2018

Treating mandatory wholesale acquisition cost disclosure in TV ads as a major drug pricing reform is close to ludicrous. But the broad approval of the action is an important sign of the continued public image cost of the ads to the drug companies.

Topic Drug approval Drug review

View article
Pink Sheet

Humira Under Pressure As NHS England Invites 'Competitive Prices' For Biosimilars

By Ian Schofield 18 Oct 2018

Companies wanting to compete in the newly off-patent adalimumab market in England have until Oct. 22 to submit their bids. They will need to offer “competitive prices” if they are to secure the highest share of sales to the national health service. At the same time, NHS trusts and clinical commissioning groups have been warned not to accept discounted interim offers from suppliers keen to get a foot in the door.

Topic Business strategies Company analysis

View article
Medtech Insight

US FDA Shelves Proposal To Mandate Home-Use Device E-Labeling

By David Filmore 18 Oct 2018

A controversial 2016 proposed rule that would have required manufacturers of many class II and class III home-use devices to electronically submit device labeling information to US FDA will not be finalized, the agency affirmed in the Oct. 17 HHS Unified Agenda document. The agency also signaled plans to imminently finalize a broad device classification rule, and other updates.

Topic Medtech

View article
Scrip

Industry Makes A Drug Price Transparency Push In DTC Ads, But Is It Too Little Too Late?

By Jessica Merrill 18 Oct 2018

PhRMA unveiled a voluntary policy under which drug makers will provide information in DTC ads about how to access drug prices and cost information. But hours later HHS issued a proposed rule on the same topic, only requiring drug makers to include WAC prices in TV ads.

Topic Drug approval Drug review

View article
Scrip

Not To Be Sniffed At: Dupixent Success In Rhinosinusitis Could Open Up Large Additional Market

By Alexandra Shimmings 18 Oct 2018

On the brink of an expanded US approval for asthma, Sanofi/Regeneron’s interleukin-4 receptor blocker Dupixent has produced positive topline Phase III data in a lucrative third indication, rhinosinusitis with nasal polyps.

Topic Influenza virus

View article
Research and Development Strategy Solutions

Stand Out as a Thought Leader with Pharma Intelligence Marketing Services: Watch the Video

15 Oct 2018

Marketing Services from Informa Pharma Intelligence connects you to the key decision makers you need to reach. Boasting the most accurate and trusted pharma and medtech intelligence in the industry.

Full video
Biomedtracker

Pharma Partnering Trends Revealed Whitepaper

12 Oct 2018

Make the most of BIO-Europe 2018 with essential partnering information from Informa Pharma Intelligence. Our insightful whitepaper, Pharma Partnering Trends Revealed: 2018 Edition, contains critical information on the landscape for biotech partnerships, and is now available for you to download – free.

View white paper
Medtech Insight

Medtech Insight Awards 2018 Video

12 Oct 2018

The inaugural Medtech Insight Awards took place on September 23 in Philadelphia. It was an exciting evening of celebration, camaraderie and spirit, and the participation and enthusiasm of everyone present helped make the event a rousing success.

Full video
Informatics Solutions

Pharma Intelligence Informatics Solutions Video

09 Oct 2018

Pharma Intelligence Informatic solutions transform how you access information and make critical business decisions, delivering trusted data on your terms, the way you want it.

Topic Strategy

Full video
Scrip

A Life In Genes - Scrip Award Winner Sir Gregory Winters Speech

03 Oct 2018

The 2015 Scrip Lifetime Achievement Award was given to Sir Gregory Winter, Master of Trinity College, Cambridge (UK). Founder of Cambridge Antibody Technology (acquired by AstraZeneca), Domantis (acquired by GlaxoSmithKline) and Bicycle Therapeutics, he is best known for his pioneering research into humanizing antibodies. His findings led to the development of the first human antibody, Humira (adalimumab), until very recently the world's top-selling drug.

Topic Drug development landscape Cancer

View article

Analysis and data

Scrip

21 Oct 2018

Dupixent Approved For Severe Asthma With Broader Label Than Other Biologics

Link
Pink Sheet

21 Oct 2018

US Drug Pricing: CMS Seeks Feedback On DTC Ad Enforcement Mechanism, Disclosure Statement

Link
Pink Sheet

21 Oct 2018

Trump Administration's Rx Drug Price Disclosure Reg Seen As Unworkable

Link
Medtech Insight

19 Oct 2018

Voters Likely To Pick And Choose Among Device Industry Favorites In Close Races

Link
Medtech Insight

19 Oct 2018

DATA: Results Recap: Neovasc's Tiara TMVR Succeeds In 12 Patients

Link
Pink Sheet

19 Oct 2018

Recent And Upcoming FDA Advisory Committee Meetings

Link
Pink Sheet

19 Oct 2018

Survey Shows Drug Makers Don't Expect To Begin Serializing All Packages By November Deadline

Link
Pink Sheet

19 Oct 2018

EU Launches Joint Assessment Of Pediatric & Orphan Drugs Legislation

Link
Scrip

19 Oct 2018

Pharma Q3 Results Preview: Biogen, Gilead, Celgene

Link
Scrip

19 Oct 2018

Deal Watch, Licensing & Alliances: Amgen Places $66m Bet On Genetic Sequencing

Link
Scrip

19 Oct 2018

Deal Watch, M&A: Warp Drive And Its Partnerships Acquired By Revolution

Link
Medtech Insight

19 Oct 2018

Only Health-Care Case At US Supreme Court This Fall Looks At Preemption

Link
Medtech Insight

19 Oct 2018

Medtronic Vet Christopher Barry Takes Helm At Nuvasive

Link
Pink Sheet

19 Oct 2018

With TheraFlu PowerPods, GSK Brews Market For OTCs From Coffee Makers

Link
Medtech Insight

19 Oct 2018

Hong Kong Medtech Regulators Face Need For System Update

Link

Featured products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Standard of care insights

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

Upcoming events

USA

Webinar

Neurmodulation Device Market - Innovations & Trends

Presenters:

David Filmore

Queensland , Australia

Industry conference

AusBiotech National Conference 2018

Denmark

Industry conference

BIO-Europe Fall 2018

View all events

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Neuromodulation Device Market - Innovations & Trends Webinar: 24 October 2018

Entries for the CARE Awards 2019 are now open

Japan Pharma Outlook 2027 Report

What's on the horizon for Neuropathic Pain?

Welcome to your Pharma Intelligence advantage

Below are the Feature List

Market intelligence

News and insight

Data and analytics

Consultancy

Global industry experts

Trusted partnerships

Gold-standard service

Tailor-made solutions

Our Specialties

Pharma Intelligence latest insights

Analyst opinion

Analysis and data

Featured products

Below are the Product Brand List

Trialtrove: gold standard clinical trials intelligence

Datamonitor Healthcare: data analysis and insight

Scrip: industry news and insights

Upcoming events

Neurmodulation Device Market - Innovations & Trends

AusBiotech National Conference 2018

BIO-Europe Fall 2018

Keep up to date

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store